Clinical Supply Regulation Resources
-
Is Your Clinical Supply Strategy Ready For EU CTR?
3/3/2022
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
Ensure Seamless, Efficient Delivery Of Clinical Trial Materials Worldwide
1/12/2023
Drug discovery companies, CROs, and CDMOs are under pressure to find supply management solutions that ensure delivery of clinical trial materials while navigating complex study designs and the regulatory landscape.
-
Sample Sizes For Performance Testing Of Combination Products, Packaging
5/16/2025
When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
Strategies To Achieve Labeling Harmonization Amid A Legal Entity Change
3/9/2023
A strong labeling team is vital to ensure successful navigation of the legal entity change process, including developing a timeline, executing data transfers, and mitigating compliance risks.
-
A Smart Solution To Clinical Supply Management
10/28/2022
Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.
-
Comparator Sourcing: How And Why To Choose A Provider
The right comparator sourcing strategy is critical. Review what sponsors need to consider when selecting the right provider in order to source the needed commercial products.
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
1/26/2026
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
IQVIA Labeling Compliance Solutions
5/16/2023
Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.
-
Compressing Analytical Timelines Without Cutting Corners
1/26/2026
Efficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
Overcome Vaccine Development Complexities With The Right Supply Chain Partner
7/5/2022
Explore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.